DSS, INC. bought IBO
March 20, 2025 · Form 4 insider transaction
DSS, INC. bought 200 shares of Impact BioMedical Inc. at $1.55 per share, a transaction worth $310.00. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$1.55
Total value
$310.00
InsiderDSS, INC.
Role—
CompanyImpact BioMedical Inc. (IBO)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 20, 2025
Filing dateMarch 24, 2025
Shares owned after53,280
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc.